Skip to main content
. 2022 Jul 13;44(6):729–737. doi: 10.1097/FTD.0000000000001006

TABLE 3.

Final Parameter Estimates Using SSE Method (n = 1000)

Parameter Description Median Mean (±95% CI) %RSE
Structural model
CL/F= θ1(Age49)θ2(PODθ3inearlyphase)(PODθ4inlatephase)
  θ1,preop Oral clearance (CL/F) before surgery (L/h) in kidney transplant patient 21.2 21.1 ± 0.0322 1.55
  θ1,postop,kidney Baseline CL/F after surgery in kidney transplant patients (L/h) 18.8 18.8 ± 0.0224 1.22
  θ1. postop,liver Baseline CL/F after surgery in liver transplant patients (L/h) 11.4 11.1 ± 0.0159 1.31
  θ2 Age effect −0.382 −0.379 ± 0.00418 11.2
  θ3,kidney POD effect in early period in kidney transplant patient 0.118 0.118 ± 0.000191 1.65
  θ3,liver POD effect in liver transplant patient 0.0582 0.0585 ± 0.000184 3.03
  θ4,kidney POD effect in late period in kidney transplant patient −0.0100 −0.0101 ± 0.000139 14.0
V/F= θ5(WT62.4)θ6
  θ5 Apparent volume (L) 510 503 ± 1.95 4.38
  θ6 Body weight effect 1.30 1.37 ± 0.0363 27.0
  ka Absorption rate constant 3.10 3.21 ± 0.0427 16.4
  ALAG1 Lag time of first-order absorption 0.25 (fix) 0.25 (fix)
Interindividual variability
 ωCL/F Interindividual variability of CL/F 0.223 0.223 ± 0.00155 7.06
 ωV/F Interindividual variability of V/F 0.826 0.829 ± 0.00699 8.57
Correlation coefficients
 ρCL/F-V/F Correlation coefficients between CL/F and V/F 0.191 0.190 ± 0.00349 18.7
Residual error
 σadd, 1* Additive error 0.0001 (fix) 0.0001 (fix)
 σprop, 1* Proportional error 0.0653 0.0657 ± 0.000754 11.7
 σadd, 2* Additive error −2.48 −2.44 ± 0.0418 17.4
 σadd, 3* Additive error 2.86 2.85 ± 0.0021 0.75
*

Number refers to the hospital where data were collected (1: Seoul National University Hospital, 2: Inje University Busan Paik Hospital, 3: Chonnam National University Hospital).

CI, confidential interval; CL, clearance; F, bioavailability; V, volume of distribution; WT, body weight.